NAMA Organizational Meeting Monday, October 8th, 7 P.M.

NAMA Organizational Meeting
Monday, October 8th, 7 P.M.

Chairs
Jo Sotheran, NAMA Board of Directors (Treasurer)
Joycelyn Woods, NAMA Board of Directors (President)
Joyce looks on as everyone gets ready...
As meeting starts Joycelyn Woods looks on over the shoulders of Tony Scro (NAMA Grievance Coordinator), James DePasquale (Long Island NAMA) and Donna Schoen (LIJ Patient Committee).
Jo talks about the NAMA chapters
Jo Sotheran introduces the reasons for discussing the relationship between the chapters and national NAMA. A more formal relationship needs to be developed however it must not interfere with grassroots advocacy. “What do you expect from NAMA?” she asks the chapters. Howard Lotsof (NAMA), Joe Neuberger (Delaware NAMA), Rokki Baker (NAMA & NAMA NorCal) and Maureen Begley (Arizona NAMA) listen to the issues.
Jo discusses the issues
Discussing chapter issues Jo Sotheran prepares to ask them about their advocacy work while Walter Ginter (NAMA) reminds the chapters how important is it to keep the grassroots aspects of methadone advocacy as Gary Nessenbaum (WAMM) looks on.
John talks Texas!
John Finger (TexNAMA and NAMA Regional Director of Southwest) reminds the group that it is the sense of belonging to a community that grassroots advocacy can bring to methadone treatment. Barbara Finger (TexNAMA and NAMA Board of Directors) takes notes.
Everyone listens to Joyce!

Carmen Pearman (The MAG), Judith Ostergard (AMMO), Norma Alexander (NAMA), Howard Lotsof (NAMA) and Joe Neuberger (Delaware NAMA) listen intently to discussions (right to left).

Carmen and Judith listen to the discussion
Carmen Pearman (The MAG) and Judith Ostergard (AMMO) listen to the comments from other chapterdiscussing their issues.
Donna What do you say?
Donna Schoen (LIJ Patient Committee) tells the group about her success at Nassau County Jail while Tony Scro (NAMA) and James DePasquale (Long Island NAMA) look on.
James joins in the discussion

James DePasquale (Long Island NAMA) talks about chapter activities while Jo Sotheran (NAMA), Walter Ginter (NAMA), Gary Nessenbaum (WAMM) and Tony Scro (NAMA Grievance Coordinator) listen.

Similar Posts

  • Managed Care Resource Guide

    Admin 07/11/2021

    Education Series Number 7 August 2003 (Revised) What is Managed Care? Managed care is a complex system that involves the active coordination of, and the arrangement for, the provision of health services and coverage of health benefits. The most common types of Managed Care Organizations (MCOs) include Health Maintenance Organizations (HMOs), Preferred Provider Organizations (PPOs)…

  • |

    Page 4098 Federal Register

    Admin 08/28/2021

     Vol. 66, No. 11 / Wednesday, January 17, 2001 / Rules and Regulations (i)                 Unsupervised or take-home use.   To limit the potential for diversion of opioid agonist treatment medications to the illicit market, opioid agonist treatment medications dispensed to patients for unsupervised use shall be subject to the following requirements.   (1)   Any patient…

  • Remember Us!

    Admin 06/03/2021

    The Writer Asks to Have Their Name Withheld for Fear of Retaliation Imagine — a young woman is in the Ladies Room stall, the Door is being held open by a worker whose job it is to observe the woman (any female patient) give a urine sample. This sample is tested for any drugs that…

  • Sample Letter

    Admin 04/08/2021

    ________________________________ Your Name ________________________________ Address ________________________________ City, State, Zip Date____________________________         Honorable Senator  ________________ United States Senate Washington, DC  20515 Dear Senator _____________________: On February 11, 1999 Senator McCain introduced S423 the Addiction Free Treatment Act. This legislation was intended as a political assault on the Office of National Drug Control Policy…

  • EXPANDED PHARMACOTHERAPIES FOR THE TREATMENT OF OPIATE DEPENDENCE

    Admin 06/23/2022

      Friday, September 25, 1998  9 a.m. to 5 p.m.          Several countries are using opiates for maintenance treatment,      including:        * codeine      * morphine      * palfium      * buprenorphine      * injectable methadone        Presenters of these pharmacotherapies will include leading clinicians      and health officials from…

  • CERTIFIED MEDICATION ASSISTED TREATMENT (MAT) ADVOCATE (CMA)

    Admin 09/12/2022

    Medication Assisted Treatment (MAT) Advocacy The National Alliance for Medication Assisted Recovery (NAMA-R) holds the view that every individual who believes in Medication Assisted Treatment (MAT) is at least a potential  Certified MAT Advocate (CMA). We encourage all supporters of MAT, patient and non-patient, to become Certified MAT Advocates so that all energies directed toward the advancement of…